Skip to main content
. 2013 Oct 5;3(1):360–375. doi: 10.1159/000353441

Table 3.

Functional status/ADL, effect sizes and p values

Author Design SCU vs. n-SCU, n Results Assessment instrument p value Cohen's d (baseline)
Orfaly Cadigan [44] longitudinal, controlled 141 vs. 31 – functional status BANS-S [88] 0.0001 not available

De Rooij [10] quasi-experimental, longitudinalc 51 vs. 51 – functional status Barthel index [52] not available −0.58
30 vs. 47 −0.53

Abrahamson [39] random, cross-sectional 665 vs. 12,442 – functional level MDS ADL [82] 0.433 0.03

Verbeek [12] quasi-experimental, longitudinal, controlledc 124 vs. 135 – ADL ADL-H [82] n.s. −0.13

Verbeek [11] cross-sectional 586 vs. 183 – functional status MDS [82] n.s. 10.72

Weyerer [31] cross-sectional, randomly selected, matched 594 vs. 573 – ADL Barthel index <0.05 −0.12

Te Boekhorst [13] quasi-experimental, longitudinal, controlledc 67 vs. 97 – ADL IDDD [89] <0.01a not available

Nobili [9] longitudinal, comparative 72 vs. 72 – functional status Barthel index 0.0005a 0.56

Pekkarinen [33] cross-sectional, selection by characteristics 390 vs. 587 – assistance in ADL MDS ADL 0.05 0.46

Ashcraft [27] cross-sectional 15 vs. 15 – ADL MDS ADL not available −0.30

Sloane [32] cross-sectional, random 773 vs. 479 – ADL impairment MDS ADL 0.001 −0.021

Reimer [14] matched groups designd 62 vs. 59 – functional status FAST [90] 0.016 not available

Luo [8] cross-sectional 750 vs. 3,667 – ADL no standardized instrumentb >0.01 −5.70

Warren [38] longitudinal, controlled 44 vs. 36 – physical status (ADL) FAM + FIM [59] not available −2.30

Chappel [25] experimental total: 323 – physical functioning MDS ADL <0.01 0.176c

Leon [21] experimental field study 432 vs. 164 – ADL limitations MDS ADL n.s. 0.07

Frisoni [34] longitudinal, controlled 31 vs. 35 – function Barthel index not available 0.31

Saxton [15] longitudinal, matched, controlledd 26 vs. 19 – total ADL FIM n.s.a 5.5
– self-care <0.05a 0.11

Phillips [45] longitudinal, matched, controlled 1,228 vs. 5,904 vs. 70,205 – ADL function MDS ADL n.s.a not available

Volicer [41] prospective cohort study 50 vs. 112 – ADL Katz ADL index [91 n.s. 0.01

Swanson [35] quasi-experimental, pre-/post-tests 13 vs. 9 – functional ability Ib FAC/ GRS [61] n.s.* 0.45
– functional ability IIb n.s.* 0.03

Lindesay [28] cross-sectionale 27 vs. 29 – dressing ABRS [78] not available 0.71
– washing 1.02
– feeding 0.36
– toileting 0.41
– mobility 0.32

Chafetz [46] quasi-experimental, longitudinal 12 vs. 8 – ADL Katz ADL index n.s.a not available

Holmes [20] quasi-experimental 49 vs. 44 – ADL Katz ADL index n.s.b 0.15

Coleman [43] experimental 47 vs. 36 – ADL functional level Katz ADL index <0.01 not available

MDS ADL = Morris scale; IDDD = Interview for the Deterioration of Daily Living Activities in Dementia; ADL-H = MDS; FAC = Functional Ability Checklist; GRS = Assessment Functioning of Geriatric Patients; ABRS = Adaptive Behaviour Rating Scale; BANS-S = Bedford Alzheimer's Nursing Severity-Subscale; n.s. = not significant.

a

Over time;

b

ADLs dependence was measured by the degree of dependence in five ADL (transferring, eating, toileting, dressing, bathing);

c

small-scale, homelike SCU/SCU comparison;

d

small-scale, homelike/n-SCU comparison;

e

SCU/n-SCU with mixed-sex population.